Filing Flows › Zymeworks (ZYME) › Q2 2026 › vs Q2 2025
Zymeworks (ZYME) Q2 2026 vs Q2 2025 (year over year)
Zymeworks's revenue fell $44.1M (-91%) from $48.7M in Q2 2025 to $4.6M in Q2 2026.
Zymeworks, Q2 2026: revenue $4.6M (-91% year over year), operating margin -919.0%, net loss $45.0M, operating cash flow −$31.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $4.6M | $48.7M | −$44.1M | -91% |
| Income tax benefit | $273K | $186K | $87K | +47% |
| Net loss | $45.0M | −$2.3M | $47.3M | — |
| Costs & expenses | $49.9M | $51.7M | −$1.8M | -4% |
| Operating costs | $46.8M | $49.4M | −$2.6M | -5% |
| Interest & other, net | $3.1M | −$2.8M | $5.9M | — |
| Research & development | $27.4M | $34.4M | −$7.0M | -20% |
| General & admin | $19.3M | $15.0M | $4.4M | +29% |
| Operating cash sources | $45.0M | −$2.3M | $47.3M | — |
| Depreciation & amortization | $1.1M | $2.5M | −$1.4M | -55% |
| Share-based compensation | $11.3M | $5.9M | $5.5M | +93% |
| Working capital & other | $604K | $1.4M | −$790K | -57% |
| Cash used in operations | $31.9M | −$12.1M | $44.0M | — |
| Net loss absorbed | $45.0M | −$2.3M | $47.3M | — |
Questions
How much did Zymeworks's revenue grow year over year in Q2 2026?
Zymeworks's revenue fell $44.1M (-91%) from $48.7M in Q2 2025 to $4.6M in Q2 2026.